Industry

Latest contract expands the Company’s state health insurance exchange market offerings to include premium billing services TYSONS, Va.–(BUSINESS WIRE)–Maximus (NYSE: MMS), a leading employer and provider of government services, today announced it has been awarded a new $31 million contract by the Massachusetts Health Connector, an independent public authority. Under the four-year base contract, Maximus … [Read more…]

OXFORD, England–(BUSINESS WIRE)–#Nanopore–At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling translational and clinical human genetics communities to deliver improved insights into mechanisms for disease in one integrated analysis. The team will highlight the unique capabilities of the PromethION in … [Read more…]

$445 million investment will support global manufacturing of Lokelma COPPELL, Texas–(BUSINESS WIRE)–AstraZeneca today announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the production of Lokelma for the benefit of patients in the United States and around the world. The investment of $445 million to expand the … [Read more…]

Financing co-led by ARCH Venture Partners and GV (Google Ventures) to support continued advancement of PP405, a topical therapy designed to reactivate dormant hair follicle stem cells to restore hair growth Positive Phase 2a results in androgenetic alopecia support progression into Phase 3 trials in 2026 Cathy Friedman of GV has been appointed Chair of … [Read more…]

BASEL, Switzerland–(BUSINESS WIRE)–Indivi and Clouds of Care, two independent TechBio companies, today announced a strategic partnership to advance the use of precision medicine tools in early-phase neuroscience drug development, targeting Alzheimer’s and Parkinson’s disease. The field of neurodegeneration remains one of the toughest challenges in medicine, with a historically low probability of technical and regulatory … [Read more…]

BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADC—Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Dorin Toader, Ph.D., as Head of Platform Technology. Dr. Toader brings more than 27 years of experience in drug discovery, including over 15 years in antibody-drug … [Read more…]

Novel ALS target identified preclinically; next phase of collaboration will leverage insitro’s ChemML™ platform to discover molecules with potential as next-generation therapies for ALS insitro’s ChemML™ platform integrates proprietary binding and ADMET data at scale with best-in-class machine learning and compute infrastructure to discover and optimize new small molecule therapeutics Collaboration extension builds on 5-year … [Read more…]

— Management to host webcast and conference call on Friday, October 24, 2025 — PASADENA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the upcoming presentation of initial results from the ongoing Phase 1 dose-escalation study of XmAb819, a bispecific ENPP3 x … [Read more…]

Partnership will bring new artificial intelligence threat detection capabilities to Analogic’s growing installed base of ConneCT Checkpoint and SeleCT Checked Baggage Computed Tomography (CT) systems PEABODY, Mass.–(BUSINESS WIRE)–Analogic Corporation, a world leader in imaging and detection solutions for aviation security and healthcare markets, and Analytical AI, a pioneer in artificial intelligence (AI) and machine learning … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it has been selected to deliver a late-breaking oral presentation at the Liver Meeting® 2025. The oral presentation will feature new … [Read more…]